DEVELOPMENT OF HEMICHANNEL-TARGETING ANTIBODY THERAPIES FOR BREAST CANCER BONE METASTASIS

$2,865,402FY2017Department of the ArmyDOD

University Of Texas Health Science Center At Houston

Investigators